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Aloes are used in traditional medicine for arthritis and
to treat skin irritations. These indications could point to
the plants having anti-inflammatory activity. Methanolic
extracts of dried leaves of 53 Aloe species were tested
in the cyclooxygenase-1 assay. Cyclooxygenase is one
of the key enzymes in the biosynthesis of
prostaglandins that are implicated in inflammatory
processes. The selected species are representative of
all chemotypes identified for the genus. The grass-like
and scandent aloes accumulate flavonoids in co-occur-
rence with the anthrone isomers aloin A and B (A.
boylei). This group is considered to be basal in Aloe and
with the exception of A. ciliaris, members of this chemo-
type showed high values of inhibition. The flavanone
producing species (A. pratensis, A. humilis and A. pre-
toriensis) also exhibited high values. These high values
are similar to those recorded for aloes which accumu-
late anthrones and chromones (A. wickensii). The two
main anthrone chemotypes in Aloe are represented by
homonataloin- and aloin accumulating species. No sig-
nificant differences could be observed between species
accumulating aloin (A. ferox) when compared to the
homonataloin-producing species (A. mitriformis). It is
interesting to note that species with similar exudate
profiles (A. mitriformis and A. comptonii) showed simi-
lar values of inhibition.
Aloes are reputed to have been used therapeutically since
Roman times (Reynolds and Dweck 1999). Aloe vera (L.)
Burm. f. and various other species are known to have been
used as purgatives, and for skin healing since the fourth
century BC (Hutchings et al. 1996). The different properties
have been ascribed to the inner, colourless, leaf gel and to
the exudate from the outer layers (Reynolds and Dweck
1999). Although the preponderant amount of research on
the genus Aloe has concentrated on Aloe vera, South Africa
harbours ca. 160 species of Aloe of which many are used in
traditional healing. In South Africa, a decoction of A. ferox
leaves or roots is used in traditional medicine for arthritis and
eczema and leaf sap of several species such as A.
arborescens and A. greatheadii is applied externally to treat
skin irritations, bruises and burns (Van Wyk et al. 1997).
These indications could point to the plants having anti-
inflammatory activity. Cyclooxygenase is one of the key
enzymes in the biosynthesis of prostaglandins that are impli-
cated in inflammatory processes. Inhibition of cyclooxyge-
nase and hence of the prostaglandin biosynthetic pathway
may lead to relief from these ailments.
A great deal of research has been conducted into the use
of aloes for the treatment of inflammation and wound heal-
ing. The treatment of inflammation is the key effect for most
types of healing, but it is now recognised that wound healing
is a complex process and that many of the constituent
processes may be addressed in different ways by different
aloe gel components (Reynolds and Dweck 1999). Penneys
(1981) found that A. vera gel and extract inhibited oxidation
of arachidonic acid in vitro. In an investigation of the effect of
A. vera on burn wounds it was found that PGF2α levels
decreased in aloe-treated wounds, while PGE2 levels
increased compared to controls (Heggers et al. 1979).
Cappaso et al. (1983) found that aloin stimulated
prostaglandin synthesis. An aqueous extract from aloe gel
containing sterols and ‘anthraglycosides’ inhibited the pro-
duction of prostaglandin E2 from arachidonic acid in vitro
(Vazques et al. 1996). A glycoprotein component of the gel,
Aloctin A, was shown to inhibit prostaglandin E2 production,
but over a relatively long incubation period compared to
acetylsalicylic acid (Ohuchi et al. 1984). Salicylic acid, which
acts as an analgesic and anti-inflammatory by inhibiting the
production of prostaglandins from arachidonic acid through
the inhibition of cyclooxygenase, has been demonstrated in
A. vera (Robson et al. 1982). Emodin, aloe-emodin and aloin
can be broken down by the Kolbe reaction to form salicy-
lates (Klein and Penneys 1988).
While it seems evident that some of the beneficial effects
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of aloe is via inhibition of prostaglandin synthesis it is still
unclear which compounds are responsible for the effects.
We therefore wanted to test a large number of African aloes
to ascertain whether certain species have potential for fur-
ther development of wound healing products. The species
selected for testing of cyclooxygenase-1 inhibitory activity
are representative of all chemotypes identified for the genus.
Materials and Methods
Leaves of each of the selected species were obtained from
the National Botanical Institute (Pretoria) and dried. One
gram of ground leaf material from each of the species was
extracted with methanol. Extracts were resuspended to a
concentration of 4mg ml-1 in ethanol and anti-inflammatory
activity determined using the cyclooxygenase-1 assay as
described by Jäger et al. (1996). Cyclooxygenase was pre-
pared from sheep seminal vesicle microsomal fractions.
Cyclooxygenase enzyme solution and co-factor solution (L-
adrenaline and reduced glutathione, 0.3mg ml-1 each in
0.1M Tris buffer, pH 8.2) were mixed in a ratio of 1:5 and
incubated on ice for 15 minutes. Sixty microlitres of this
enzyme/co-factor solution was added to 20μl of sample
(2.5μl of ethanolic extract + 17.5μl water). Twenty microlitres
of 14C-arachidonic acid (30μM, 17Ci mol-1) was added and
the assay mixture incubated for 8 minutes at 37°C. The
reaction was terminated by adding 10μl 2N HCl. Background
samples containing inactivated enzyme to which 14C-arachi-
donic acid was added, were kept on ice. Four microlitres of
a 0.2mg ml-1 carrier solution of unlabelled prostaglandins
(PGE2:PGF2 1:1 v/v) were added.
The prostaglandins were separated from the unmetabolised
arachidonic acid by column chromatography. Silica gel in
eluent 1 (hexane:dioxane: acetic acid 350:50:1v/v) was
packed to a height of 3cm in Pasteur pipettes. One millilitre
of eluent 1 was added to the samples and this mixture was
applied to the columns. The arachidonic acid was eluted
from the column with 4ml of eluent 1 and discarded.
Labelled prostaglandins were eluted with 3ml of eluent 2
(ethyl acetate:methanol 85:15v/v). Four millilitres of scintilla-
tion fluid were added to each vial and the radioactivity meas-
ured using a Beckman LS6000LL scintillation counter.
Percentage inhibition of test solutions was calculated by
comparing the amount of radioactivity present in the sample
to that in the solvent blank. In order to determine the validi-
ty of the assay-system an ethanolic indomethacin standard
solution was assayed each time samples were tested in the
assay. Assays were performed in duplicate.
Results and Discussion
The results of the screening for cyclooxygenase-1 inhibito-
ry activity and a summary of the exudate chemistry are
given in Table 1. Figure 1 shows representative HPLC pro-
Figure 1: Representative chromatograms of Aloe species tested for anti-inflammatory activity. Peak number correspond to compounds in
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files of the leaf exudate compounds for some of the species
studied.
The grass-like aloes (Aloe boylei, Figure 1b) and scandent
aloes (Aloe commixta, Figure 1d) accumulate flavonoids, and
in the case of the latter group the flavones are in co-occur-
rence with the anthrone isomers aloin A and B. The grass-like
aloes and the scandent aloes are considered basal in Aloe
(Viljoen et al. 1998) and with the exception of A. ciliaris,
members of this chemotype showed high values of inhibition.
The flavanone producing species (A. pratensis, A. humilis
and A. pretoriensis) also exhibited high values. These values
are similar to those recorded for aloes which accumulate
anthrones and chromones. The two main anthrone chemo-
types in Aloe are represented by homonataloin and aloin
accumulating species (Viljoen 1999). No noteworthy differ-
ences could be observed between species accumulating
aloin (A. arborescens, Figure 1a, A. broomii, Figure 1c) when
compared to the homonataloin producing species (A. mitri-
formis, Figure 1g, and A. wickensii, Figure 1i). Based on a
single chemical marker, microstigmin (compound 10 in
Figure 1) Viljoen (1999) unites A. broomii and A. microstigma
in the same chemotype. Aloe microstigma however shows
very low levels of inhibition (ca. 30%) while A. broomii
exhibits much higher levels of inhibition (89%). Inspection of
their HPLC chromatograms however show that although
microstigmin is accumulated in both species the chro-
matograms are very different with respect to the chromone
constituents. Hutter et al. (1996) demonstrated the anti-
inflammatory action of an isolated chromone from Aloe vera.
More specifically, the anti-inflammatory action was demon-
strated for the chromone containing the cinnamoyl ester.
Cinnamoyl chromones are accumulated in Aloe broomii (27
in Figure 1c), A. comptonii and A. mitriformis (11 and 17 in
Figure 1g). All three of these species showed very high lev-
els of inhibition. It is interesting to note that species with sim-
ilar exudate profiles such as A. mitriformis and A. comptonii
(Viljoen and Van Wyk 1999) show similar values of inhibition.
In contrast, the species which accumulate identical exudate
phenolics (A. plicatilis and A. morijensis only accumulate pli-
cataloside) exhibit very different values of cyclooxygenase
inhibition. It remains unclear however which group of chemi-
cal compounds (chromones, anthrones, phenyl pyrones,
flavonoids, naphthalene compounds) are contributing to the
observed anti-inflammatory activity. The other component of
any aloe leaf is the inner gel which is composed of polysac-
charides. The gel of various species have been analysed by
NMR analysis and the results indicate that the gel composi-
tion varies between species (Diehl 2000).
The contribution of exudate phenolics alone to the
observed cyclooxygenase-1 inhibitory activity requires fur-
ther investigation as species devoid of chromones,
anthrones and flavonoids, which are generally detected in
Aloe, also exhibited activity. It would be interesting to deter-
mine which compounds in the leaf exudate and/or gel con-
tribute to the anti-inflammatory activity in this medicinally
important genus.
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Species %1 Leaf exudate compounds
A. arborescens (1) 96 1, 3, 16, 18
A. arborescens (2) 67 1, 3, 16, 18
A. arborescens (3) 76 1, 3, 16, 18
A. barberae2 68
A. boylei 91 12
A. broomii 89 1, 10, 13, 14, 18, 27
A. bulbilifera2 96
A. capitata var. gneissicola 83 2, 18
A. castanea 82 1, 18, 19
A. ciliaris 34 12
A. commixta 93 1, 12, 18
A. comptonii 83 1, 11, 17, 20
A. conifera 48 1, 8, 20
A. deyeri2 85
A. dichotoma2 25
A. dinteri2 38
A. divaricata 7 2, 18
A. dumatorum2 75
A. eminens2 0 18
A. esculenta 90 2, 5, 15, 21, 23
A. excelsa 25 1, 2, 8, 16, 18
A. ferox 80 1, 8, 13, 18, 22
A. globuligemma2 96
A. harlana 73 2, 18, 22, 24
A. hemmingii 92 1, 6, 18, 22
A. humilis 94 25
A. jacksonii2 23 1
A. juvenna2 86
A. karasbergensis2 31
A. kedongensis 82 1, 2, 3, 26
A. marlothii 30 1, 8, 16, 18
A. microstigma2 (1) 25 1, 2, 10, 13
A. microstigma2 (2) 36 1, 2, 10, 13
A. mitriformis 94 1, 8, 11, 17, 20
A. morijensis 16 9
A. occidentale 79 1, 8, 12, 18
A. parvula2 93
A. pendens2 64
A. plicatilis 92 9
A. pluridens2 94
A. pratensis 79 25
A. pretoriensis 83 25
A. ramossissima2 67
A. schelpei 5 6, 18, 24
A. secundiflora 77 3, 16, 18
A. sessiliflora 92 1, 18, 19
A. speciosa2 76 20
A. succotrina2 46 1, 26
A. suprafoliata (1) 90 1, 8, 20
A. suprafoliata (2) 63 1, 8, 20
A. suzannae 81 12, 25
A. teniour 89 1, 12, 18
A. vaombe2 35
A. vaotsanda 91 1, 16, 25
A. verdoorniae2 76
A. viridiflora 79 1, 8, 20
A. wickensii (1) 97 1, 4, 7, 20, 28
A. wickensii (2) 89 1, 4, 7, 20, 28
1 Percentage inhibition of cyclooxygenase
2 Species contain, in addition to compounds 1–26 various com-
pounds which have not been identified and only ha,ve a restricted
occurrence in Aloe.
Table 1: The presence of leaf exudate compounds in Aloe species
tested for the inhibition of cyclooxygenase
1 = aloesin, 2 = 7-hydroxyaloesin, 3 = aloenin, 4 = homonataloside B, 5 = 10-hydroxyaloin B, 6 = 8-O-methyl-7-hydroxyaloin, 7 = 3’-O-
coumaroylaloesin, 8 = aloeresin A, 9 = plicataloside, 10 = microstigmin, 11 = aloeresin E, 12 = isovitexin, 13 = 5-hydroxyaloin B, 14 = broomii
chromone I, 15 = 10-hydroxyaloin-6’-monoacetate, 16 = aloeresin D, 17 = aloeresin F, 18 = aloin A & B, 19 = 6-O-coumaroylaloesin, 20 =
homonataloin A & B, 21 = deacetyllittoraloin, 22 = aloinoside A & B, 23 = littoraloin, 24 = microdontin A & B, 25 = flavanones, 26 = nataloin A
& B, 27 = broomii chroíone II, 28 = 3’6’-di-O-coumaroylaloesin
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